NeurologyLive Peer Exchange

A panel of experts in dementia discusses the latest progress in the treatment of Alzheimer disease, and the various therapies that have progressed through the pipeline.

An expert Brazilian panel review the state of diagnosis and treatment of SMA, highlighting available treatments and factors that guide treatment selection.

Neurologistas e especialistas clínicos discutem diagnóstico e tratamento da Atrofia Muscular Espinhal (AME) na população pediátrica do Brasil. Eles destacam tratamentos disponíveis, pacientes ideais para cada tratamento, necessidades de monitoramento e importância do cuidado multidisciplinar no manejo da AME

A panel of experts in neurology discuss comorbidities in multiple sclerosis and the use of sphingosine 1-phosphate receptor modulators for treatment. They discuss data on sequencing of disease modifying therapies and challenges and their approaches to guiding patients through treatment discontinuations.

An expert cardiologist, sleep specialist, and pulmonologist, share insights on the awareness and treatment of sleep disorders, including insomnia, that co-occur with other health conditions.

Experts in neurology provide insight on neuromyelitis optica spectrum disorder (NMOSD) in racially and ethnically diverse patient populations, highlighting treatment considerations and engaging patients in clinical trial and therapeutic development.

Experts in neurology share considerations for the management of ethnically diverse and underrepresented populations including those of reproductive age who have the Epstein-Barr virus.

Experts in neurology discuss changes in cognitive health and the role of sphingosine-1-phospate receptor modulators and disease-modifying therapies play in multiple sclerosis management.

Expert neurologists discuss the impact of MS on the immune system and comment on the use of COVID-19 vaccines with MS treatment and the use of high efficacy therapies in MS.

Experts in movement disorders highlight the importance of patient and provider education around OFF episodes and share strategies for optimizing the management of OFF episodes in the Parkinson disease treatment landscape.

In this Peer Exchange special edition, Scott Newsome, DO, leads a discussion with Alberto Ascherio, MD, DrPH; Anne Cross, MD; Avindra Nath, MD; and Michael Racke, MD, about the practical and clinical implications of a recently published novel longitudinal study, the first of its kind to draw a causal link between Epstein-Barr Virus and multiple sclerosis.

Jessica Ailani, MD; Bradley Torphy, MD; Sait Ashina, MD; Andrew C. Charles, MD; and Julio R. Vieira, MD, share expert approaches to the diagnosis and treatment of acute and preventive migraine and discuss key insights on the evolving treatment landscape.

Expert panelists review insomnia diagnosis and clinical manifestations, non-pharmacological management, pharmacological treatment options, and new agents on the horizon.

Expert neurologists provide a discussion on current treatment options for migraine and review data from recent clinical trials.

Experts discuss the causes, impact on quality of life, and the management of morning OFF episodes in Parkinson’s disease.

Recommendations for selecting and sequencing therapies used to treat patients with relapsing multiple sclerosis.

Fred D. Lublin, MD; Ravi Dukkipati, MD; Gavin Giovannoni, MD; and Lauren Gluck, MD explore several topics pertaining to the diagnosis and treatment of relapsing multiple sclerosis (MS), including current treatment options, therapy sequencing, and the future of MS management.

Neurology experts discuss the diagnosis and treatment of advanced Parkinson disease.

Panelists discuss recommendations for the diagnosis, treatment, and management of patients with Dravet Syndrome.

Recommendations for appropriate treatment selection and use of high efficacy therapies as treatment for relapsing-remitting multiple sclerosis.

Crystal Proud, MD; Claudia Chiriboga, MD, MPH; Tom Crawford, MD; Basil Darras, MD; and Carolina Tesi Rocha, MD provide a discussion on the importance of early diagnosis and treatment of spinal muscular atrophy and consider data from recent clinical trials of disease-modifying therapy options.

Richard S. Bedlack, MD, PhD, MS; Ammar Al-Chalabi, MB, ChB, PhD; Jinsy A. Andrews, MD, MSc; and Jeremy M. Schefner, MD, PhD discuss the current treatment landscape for amyotrophic lateral sclerosis (ALS) and provide insights into ongoing clinical trials and recent results.

Experts discuss the diagnosis and treatment of progressive multiple sclerosis.

Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.

Fred Lublin, MD; Patricia K. Coyle, MD; Mark Freedman, MD; and Scott D. Newsome, DO, discuss a number of topics pertaining to the diagnosis of multiple sclerosis, including a focus on fatigue and its impact on quality of life.